Case Report: Omalizumab-Associated Hair Loss: A Case of Eyebrow Alopecia Areata, Literature Review and FAERS Database Analysis
June 2025
in “
Frontiers in Medicine
”
Studysummary This study observed that omalizumab may induce alopecia, particularly in females aged 18-60, though establishing a direct cause-effect link remains challenging. Alopecia areata was noted as a possible uncommon, yet transient, hair loss type associated with omalizumab.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →